Literature DB >> 1606999

A comparison of the effects of fluvoxamine and amitriptyline on autonomic functions in healthy volunteers.

S R Flett1, E Szabadi, C M Bradshaw.   

Abstract

We have compared the effects of single oral doses of fluvoxamine (50 mg and 100 mg), amitriptyline (50 mg and 100 mg), and placebo on some autonomic functions in ten healthy volunteers, using a balanced, double-blind, crossover design. Amitriptyline significantly reduced salivation, the miosis evoked by locally applied pilocarpine, and the sweat secretion evoked by locally applied carbachol. Fluvoxamine also significantly attenuated carbachol-evoked sweat gland activity, although to a smaller degree than amitriptyline; fluvoxamine did not significantly alter salivation or pilocarpine-evoked miosis. Neither treatment significantly altered the miotic responses evoked by brief light stimuli. Heart rate and blood pressure were not greatly affected by either treatment, although the fall in heart rate (erect posture) with placebo was significantly reduced by amitriptyline (100 mg). The results suggest that fluvoxamine has some anti-muscarinic activity in man, but is considerably less potent in this respect than amitriptyline.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1606999     DOI: 10.1007/BF00314863

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  15 in total

1.  A gas chromatographic method for the determination of amitriptyline and nortriptyline in human serum.

Authors:  A Jorgensen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975-01

2.  Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro.

Authors:  E Richelson; A Nelson
Journal:  J Pharmacol Exp Ther       Date:  1984-07       Impact factor: 4.030

3.  Fluvoxamine, a specific 5-hydroxytryptamine uptake inhibitor.

Authors:  V Claassen; J E Davies; G Hertting; P Placheta
Journal:  Br J Pharmacol       Date:  1977-08       Impact factor: 8.739

4.  A double-blind placebo-controlled study to compare the autonomic effects of fluvoxamine with those of amitriptyline and doxepin in healthy volunteers.

Authors:  W H Wilson; H Higano; Y Papadatos; S Kelwala; T A Ban
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

5.  A technique for studying the effects of drugs on human sweat gland activity.

Authors:  M Clubley; C E Bye; T Henson; A W Peck; C Riddington
Journal:  Eur J Clin Pharmacol       Date:  1978-11-27       Impact factor: 2.953

6.  Effects of locally and systemically administered cholinoceptor antagonists on the secretory response of human eccrine sweat glands to carbachol.

Authors:  J Longmore; C M Bradshaw; E Szabadi
Journal:  Br J Clin Pharmacol       Date:  1985-07       Impact factor: 4.335

7.  The peripheral anticholinergic activity of tricyclic antidepressants: comparison of amitriptyline and desipramine in human volunteers.

Authors:  E Szabadi; P Gaszner; C M Bradshaw
Journal:  Br J Psychiatry       Date:  1980-11       Impact factor: 9.319

8.  A placebo controlled study of the cardiovascular effects of fluvoxamine and clovoxamine in human volunteers.

Authors:  J F Robinson; D P Doogan
Journal:  Br J Clin Pharmacol       Date:  1982-12       Impact factor: 4.335

9.  Pharmaco-EEG profiles of antidepressants. Pharmacodynamic studies with fluvoxamine.

Authors:  B Saletu; J Grünberger; P Rajna
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

10.  A double-blind placebo-controlled study of fluvoxamine and imipramine in out-patients with primary depression.

Authors:  T M Itil; R K Shrivastava; S Mukherjee; B S Coleman; S T Michael
Journal:  Br J Clin Pharmacol       Date:  1983       Impact factor: 4.335

View more
  9 in total

Review 1.  Spotlight on fluvoxamine in anxiety disorders in children and adolescents.

Authors:  Susan M Cheer; David P Figgitt
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 2.  Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects.

Authors:  G J H Dumont; S J de Visser; A F Cohen; J M A van Gerven
Journal:  Br J Clin Pharmacol       Date:  2005-05       Impact factor: 4.335

Review 3.  Fluvoxamine. An updated review of its use in the management of adults with anxiety disorders.

Authors:  D P Figgitt; K J McClellan
Journal:  Drugs       Date:  2000-10       Impact factor: 9.546

Review 4.  Fluvoxamine: a review of its therapeutic potential in the management of anxiety disorders in children and adolescents.

Authors:  S M Cheer; D P Figgitt
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

5.  A comparison of the effects of fluvoxamine and amitriptyline on autonomic functions in healthy volunteers.

Authors:  S R Flett; E Szabadi; C M Bradshaw
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

6.  Vagal tone is reduced during paced breathing in patients with the chronic fatigue syndrome.

Authors:  S A Sisto; W Tapp; S Drastal; M Bergen; I DeMasi; D Cordero; B Natelson
Journal:  Clin Auton Res       Date:  1995-06       Impact factor: 4.435

Review 7.  Fluvoxamine. An updated review of its pharmacology, and therapeutic use in depressive illness.

Authors:  M I Wilde; G L Plosker; P Benfield
Journal:  Drugs       Date:  1993-11       Impact factor: 9.546

8.  Arousal and the pupil: why diazepam-induced sedation is not accompanied by miosis.

Authors:  R H Hou; E R Samuels; R W Langley; E Szabadi; C M Bradshaw
Journal:  Psychopharmacology (Berl)       Date:  2007-07-22       Impact factor: 4.530

9.  Fluvoxamine in the treatment of anxiety disorders.

Authors:  Jane Irons
Journal:  Neuropsychiatr Dis Treat       Date:  2005-12       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.